These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3969596)

  • 1. Plasma exchange in Goodpasture's syndrome.
    O'Donnell D
    S Afr Med J; 1985 Jan; 67(4):119-20. PubMed ID: 3969596
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane plasma exchange in Goodpasture's syndrome.
    Keller F; Offermann G; Schultze G; Wagner K; Aulbert E; Scholle J; Faber U; Maiga M; Pommer W
    Am J Med Sci; 1984; 287(3):32-6. PubMed ID: 6731478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-site avascular necrosis. A complication of Goodpasture's syndrome treated with plasma exchange and corticosteroids.
    Boyle PD; Balmer JP; Craswell PW; Johnson FL
    Med J Aust; 1982 Oct; 2(9):437-8. PubMed ID: 7177019
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoadsorption in Goodpasture's syndrome.
    Laczika K; Knapp S; Derfler K; Soleiman A; Hörl WH; Druml W
    Am J Kidney Dis; 2000 Aug; 36(2):392-5. PubMed ID: 10922318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goodpasture's syndrome with asymptomatic renal involvement. Disappearance of antiglomerular basement membrane antibodies deposits after treatment.
    Lamriben L; Kourilsky O; Mougenot B; Ronco P; Sraer JD
    Nephrol Dial Transplant; 1993; 8(11):1267-9. PubMed ID: 8302468
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of Goodpasture's syndrome complicated with cytomegalovirus pneumonia during treatment with plasma exchange and immunosuppressive therapy].
    Hasegawa K; Hiraoka N; Nagahara H; Tokuda S; Shiotsu S; Takumi C
    Nihon Kokyuki Gakkai Zasshi; 2010 Oct; 48(10):743-8. PubMed ID: 21066862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal relapse in Goodpasture's syndrome 3 years after plasma exchange.
    Keller F; Nekarda H
    Respiration; 1985; 48(1):62-6. PubMed ID: 4023439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Goodpasture's syndrome. Development of its prognosis from 1955 to 1982].
    Marcandoro J; Sobel A
    Presse Med; 1983 May; 12(23):1483-7. PubMed ID: 6222345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral vasculitis in a teenager with Goodpasture's syndrome.
    Gittins N; Basu A; Eyre J; Gholkar A; Moghal N
    Nephrol Dial Transplant; 2004 Dec; 19(12):3168-71. PubMed ID: 15575006
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
    Hind CR; Bowman C; Winearls CG; Lockwood CM
    Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture's syndrome in childhood: treatment with plasmapheresis and immunosuppression.
    McCarthy LJ; Cotton J; Danielson C; Graves V; Bergstein J
    J Clin Apher; 1994; 9(2):116-9. PubMed ID: 7798157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary-renal syndrome and Goodpasture's syndrome].
    Morita H; Ideura T
    Nihon Rinsho; 2004 May; 62 Suppl 5():421-5. PubMed ID: 15197957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current aspects of Goodpasture's syndrome].
    Carré P; Rakatoarivony J; Didier A; Lloveras JJ; Léophonte P
    Rev Mal Respir; 1988; 5(4):319-30. PubMed ID: 3051195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Goodpasture's disease by plasma exchange and immunosuppression.
    Swainson CP; Robson JS; Urbaniak SJ; Keller AJ; Kay AB
    Clin Exp Immunol; 1978 May; 32(2):233-42. PubMed ID: 668199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial recovery of renal function in an oligoanuric patient affected with Goodpasture's syndrome after treatment with steroids, immunosuppressives and plasmapheresis.
    Fort J; Espinel E; Rogriquez JA; Curull V; Madrenas J; Piera L
    Clin Nephrol; 1984 Oct; 22(4):211-2. PubMed ID: 6509807
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome.
    Erickson SB; Kurtz SB; Donadio JV; Holley KE; Wilson CB; Pineda AA
    Mayo Clin Proc; 1979 Nov; 54(11):714-20. PubMed ID: 491763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goodpasture's disease.
    Salama AD; Levy JB; Lightstone L; Pusey CD
    Lancet; 2001 Sep; 358(9285):917-20. PubMed ID: 11567730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.